clofarabine
0 sources
clofarabine
Summary
clofarabine is a type of chemical entity[1]. clofarabine ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (39 views/month).[2]
Key Facts
- clofarabine's instance of is recorded as type of chemical entity[3].
- clofarabine's physically interacts with is recorded as Ribonucleotide reductase catalytic subunit M1[4].
- clofarabine's physically interacts with is recorded as Ribonucleotide reductase regulatory subunit M2[5].
- clofarabine's canonical SMILES is recorded as C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl[6].
- clofarabine's chemical formula is recorded as C₁₀H₁₁ClFN₅O₃[7].
- clofarabine is a type of 5-(6-amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol[8].
- clofarabine is used for medication[9].
- clofarabine's Commons category is recorded as Clofarabine[10].
- clofarabine's isomeric SMILES is recorded as C1=NC2=C(N1[C@H]3C@HF)N=C(N=C2N)ClC@HF)N=C(N=C2N)Cl">[11].
- clofarabine's mass is recorded as {'unit': 'Q483261', 'amount': '+303.053'}[12].
- clofarabine's medical condition treated is recorded as acute myeloid leukemia[13].
- clofarabine's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'clofarabine'}[14].
- clofarabine's subject has role is recorded as DNA polymerase inhibitors[15].
- clofarabine's subject has role is recorded as antineoplastic antimetabolite[16].
- clofarabine's active ingredient in is recorded as Evoltra[17].
- clofarabine's active ingredient in is recorded as Clolar[18].
- clofarabine's has active ingredient is recorded as Clofarabine[19].
- clofarabine's LiverTox likelihood score is recorded as LiverTox toxicity likelihood category D[20].
Why It Matters
clofarabine ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (39 views/month).[2] clofarabine has Wikipedia articles in 7 language editions, a strong signal of global cultural recognition.[21] clofarabine is known by 18 alternative names across languages and contexts.[22]